Press Release from the Ministry of Health and Wellness - 2024/05/15:
The Ministry of Health & Wellness has noted the public discourse over the COVID-19 vaccine, AstraZeneca (AZ), following the withdrawal of the marketing authorization as requested by the manufacturer.
The
Vaxzevria - COVID-19 Vaccine formulation (ChAdOx1-S [recombinant]),
manufactured by AZ was authorized for emergency use during the height of the
pandemic. Over 3 billion doses were distributed in over 150 countries globally.
Independent studies showed high effectiveness of the AZ vaccine in preventing
serious illness and deaths. It is estimated that over 6 million lives were
saved in the first year of use of AZ vaccine, which was the only available
vaccine in many countries.
The
AZ vaccine, however, was replaced by use of mRNA vaccines in many countries as
these vaccines became more widely available. The manufacturers did not update
the AZ vaccine to target newer strains of the SARS-CoV-2 virus that causes
COVID-19 and there was further decline in the uptake of the AZ vaccine with the
increase in the availability of newer formulations currently in surplus on the
global market that protect against emerging strains of SARS-CoV-2.
This
decreasing demand has resulted in Vaxzevria no longer being manufactured or
supplied. Serum Institute of India which produced the COVISHIELD AZ vaccine, the
main product used in Jamaica, stopped manufacturing and supplying doses since
December 2021.
Due
to its absence from the global market, AZ has not been available for use in
Jamaica since 2022. The last shipment of AZ vaccine was received in May 2022
and the last available batch expired in July 2022.
As at May 10, 2024, a total of 1,534,738 doses of COVID-19 vaccines have been administered in Jamaica. Of this number, approximately 59% were AZ, 40% were Pfizer and less that 1% were SinoPharm, Johnson & Johnson and Moderna vaccines.
The
Ministry wishes to further advise the public that, in Jamaica, it continues to
collect reports on illnesses that have occurred in vaccinated persons, where
there is a possibility of relation to the vaccine.
Thrombosis
with Thrombocytopenia Syndrome (TTS) is a very rare side effect associated with
the use of the AZ vaccine. There have been no confirmed cases of TTS in
Jamaica. TTS usually occurs within three to 30 days of vaccination.
COVID-19 Vaccines in Stock
Pfizer,
Johnson & Johnson and SinoPharm vaccines were available for administration
in 2023, with stock out of all COVID-19 vaccines in September 2023. The
Ministry of Health & Wellness currently has no AZ, Johnson & Johnson,
or Sinopharm vaccine doses remaining in stock.
As
at May 8, 2024, there were 17,300 doses of Pfizer vaccine in stock at central
stores.
The
benefit of administering COVID vaccines, especially to high-risk groups,
continues to outweigh the risks and the World Health Organization (WHO)
continues to recommend vaccination of high-risk groups (elderly, persons with
comorbidities, health workers, pregnant women) to protect against severe
outcomes using any available vaccine.
____________________
Alert
I just got information that there is a dead person on the grounds of Pembroke Hall Primary in Kingston. The little children are disturbed by the site. Could someone living in the area use something to cover the body?
____________________
.jpeg)
Please delete that nonsense press release from your blog. It is saying absolutely nothing.THEY KEEP TAKING THE JAMAICAN PUBLIC FOR HEEDIOTS..SMDH
ReplyDeleteI agree with the comment that they are taking Jamaicans for fools.. The vaccine has caused more destructions rather than good. I guess that was the objective.
ReplyDeleteI know many people who have died from cancer, stroke, heartattack, aneurysm...and they have no member with those illnesses . This is a direct cause from the poisonous vaccine. They can't fool us anymore with their plandemic
ReplyDelete